Category: CannabisNewsWire Release

Flora Growth Corp. (NASDAQ: FLGC) Adding to Cannabis Product Line, Research

  • Flora Growth is building on its cannabis brand globalization efforts with two partnerships that expand its product portfolio and its research efforts in the United States and United Kingdom
  • Flora’s partnership with former NFL athlete Ricky Williams has delivered its first product — a cannabis one-hitter accessory designed to provide a unique experience emblematic of Williams’ active lifestyle brand
  • The company’s acquisition of the Masaya CBD brand developed by a cell biologist on Flora’s board of directors gives the company a formulation suitable for its current clinical trial efforts in the United Kingdom, and a well-received brand designed to help seizure patients
  • Flora’s cultivation operations are centered at its Colombia facility, and recent regulatory changes there have made it easier for Flora to supply its brands in the United States and elsewhere

On the heels of a year in which global cannabis market brand-builder Flora Growth (NASDAQ: FLGC) saw rapid expansion of its cultivation, manufacturing and distribution operations that support the company’s business divisions for cosmetics, hemp textiles and food and beverage products, Flora is increasing its offerings by bringing a promising  CBD brand into its fold and introducing a new product for quality cannabis experiences. 

The acquisition of cell biologist Dr. Annabelle Manalo-Morgan’s Masaya brand gives Flora Growth its first offering under its Flora Life Sciences division as well as a patent-pending formulation for use in Flora’s current clinical trials with the University of Manchester in the United Kingdom (https://cnw.fm/05Tev).

The launch of the global clinical trials was announced in October, heralding an effort to study the effects of Flora’s cannabis on fibromyalgia and chronic pain patients (https://cnw.fm/Fu6lQ). Manalo-Morgan developed the formulation for Masaya after her son was born with a condition that led him to suffer from as many as 200 seizures per day. 

Manalo-Morgan’s son initially underwent surgery that removed nearly 40 percent of his brain, but Manalo-Morgan’s discovery of CBD’s medicinal potential and development of Masaya’s formulation provided her a non-surgical path for ensuring her son’s well-being. 

“He has no developmental deficits. If you saw him, you would never know there was a thing wrong with him. He is not autistic, delayed, nothing. He is a normal 5-year-old boy,” Manalo-Morgan told a news reporter as her son prepared to enter kindergarten last year (https://cnw.fm/DjMth). “If I didn’t do this, my son would most likely be tied to a wheelchair, wouldn’t speak, would still be eating out of a tube. But luckily his mom is a scientist.”

Masaya has been used by thousands of consumers since its development with positive testimonials. 

“Amplifying Dr. Annabelle and her son’s beautiful story and improving the well-being of people around the world is our aim,” Flora Chairman and CEO Luis Merchan stated in the company’s news release. “This acquisition allows us to deliver on our promise to invest in safe, thorough, cutting-edge scientific research that can bring meaningful change via an efficacious and accessible product offering for people worldwide.”

On May 18, Flora also announced the development of a custom accessory for cannabis use in collaboration with cannabis lifestyle brand Highsman, which was founded by former NFL running back Ricky Williams. 

The patent-pending Highsman Helix one-hitter accessory is the first product introduced under the partnership between Highsman and Flora’s cannabis accessories brand Vessel (https://cnw.fm/ipHTH). It is crafted in non-toxic brass and uniquely designed to offer “the perfect combination of filtering and cooling.” 

Vessel’s other luxury accessories include a high-end line of vape pen batteries and dry-herb accessories, while Highsman also markets apparel and other accessories designed to appeal to people with active lifestyles, inspired by Williams’ success. 

For more information, visit the company’s website at www.FloraGrowth.com.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — States Grapple with Setting Regulations for Hemp-Derived Intoxicating Products

America’s hemp industry has been plagued by one major issue since the 2018 Farm Bill legalized industrial hemp: federal inaction. While the legislation allowed the cultivation and sale of industrial hemp under state programs, lawmakers did not create a comprehensive regulatory structure for hemp or hemp-derived products.

The result is a sector that has been referred to as a “wild west” where businesses barely have any rules governing how they operate and which products they can put out into the market. One of the core provisions for legalizing industrial hemp was that it had to contain less than 0.3% delta-9 THC, which is the main intoxicating agent in marijuana.

However, lack of federal action has led to the proliferation of cannabinoids other than delta-9 THC with the ability to intoxicate users. States are now grappling with how to deal with psychoactive cannabinoids such as delta-8 THC, which aren’t explicitly covered in the Farm Bill’s language.

In Tennessee, for instance, the market has been flooded by unregulated products dubbed “frankenweed” due to claims of them being created in laboratories. Lawmakers were faced with the choice of either banning delta-8 THC and other psychoactive hemp-derived cannabinoids or setting safety standards for the market.

Nashville lawmakers were unable to make a decision early enough, leaving the state inundated with intoxicating and possibly dangerous THC products with no safety oversight or age requirements for purchasing. Hemp Alliance of Tennessee president Frederick Cawthon calls the entire ordeal a “roller-coaster ride.”

Federal ambiguity regarding hemp-derived products is to blame for this regulatory roller coaster. The greatest beneficiary of this ambiguity has been CBD, a hemp extract said to have medical applications. As long as the hemp they were derived from met the less than 0.3% delta-9 THC threshold, cannabinoids such as CBD and delta-8 THC are considered legal.

This ambiguity also means that hemp operators may act contrary to some food and drug laws despite following hemp laws. The U.S. Food and Drug Administration (FDA), which has been charged with creating concise hemp rules, has barely made a move to regulate the multitude of hemp extracts that are steadily emerging.

Denver-based lawyer Shawn Hauser says the FDA’s inaction has forced states to step up and craft their own rules for dealing with hemp-extracted intoxicants. During a recent webinar meant to help unravel the resulting complex patchwork of hemp regulations, Hauser said that states still run into problems when they try to set limits on synthetic, or‘intoxicating, hemp products as federal law has no definition for these terms.

Colorado, Kentucky, Virginia and at least 10 other states have considered proposals designed to regulate the sale of hemp derivatives this year while the Minnesota and Maryland legislatures have already passed bills to place limits on the sale of hemp intoxicants.

The lack of federal regulations governing commerce in hemp derivatives poses a big challenge to industry actors, such as Flora Growth Corp. (NASDAQ: FLGC), that would like to establish their footprint across different jurisdictions. This is because it is hard to tweak different products in order to adhere to the patchwork of rules (where they exist) in different states.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Maryland Official Wants DOJ to Investigate Possible Flaws in FBI Cannabis Arrest Data

An official in Maryland is asking that the Department of Justice formally investigate the system of reporting used by the FBI for local and state cannabis arrests. The key issue is the confusion among agencies of law enforcement on the issuance of citations for the possession of marijuana under decriminalization laws in the state and whether they should be reported as arrests to the FBI.

This confusion has caused inconsistency in the data that is released annually, calling into question the data’s use as a tool to inform policymaking on cannabis. The reporting system, which is known as the Uniform Crime Reporting program, is depended on by researchers, legislators and media to examine and understand law enforcement trends, with more than 18,000 jurisdictions in the country reporting to the agency on why and how many types of arrests are made annually using it.

Maryland official Eric Sterling believes that the arrest data on marijuana that was reported through the program may be embellished after a state police department recently revealed in an interview that they categorized simple civil violations for the possession of marijuana as arrests.

The state of Maryland decriminalized cannabis in 2014 and made the possession of 10 grams of the herb a civil violation punishable by a fine without the threat of jail time or even arrest.

Despite the lack of arrest for such a violation, state police in Maryland report fine issuance as arrests. This is because the National Incident-Based Reporting System manual instructs that violation of laws that prohibit the use, distribution or production of some controlled substances be reported but offers no distinction between criminal arrests and civil violations.

This apparent inconsistency is what prompted Sterling to demand an investigation be done by the Office of the Inspector General. Sterling explained that miscounted arrests undermined the value of cannabis decriminalization as a cost saver for law enforcement, noting that the arrest data may influence federal funding for local and state police departments under several programs.

The issue may have considerable implications for observers and policymakers evaluating the impact of decriminalization policies. An analysis has shown that this interpretation hasn’t been adopted in all departments, with some reporting substantially less cannabis arrests postdecriminalization.

It is not clear how many police agencies in the country classify citations as arrests. However, cities such as Baltimore are using a different reporting style, with far fewer marijuana arrests being reported since its state enacted decriminalization laws.

The response to this appeal is likely to be of interest to the entire marijuana industry, including entities such as Cannabis Strategic Ventures Inc. (OTC: NUGS) because FBI data on different arrests plays a crucial role in informing what stance policy makers at the highest level take.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Closes $5M Direct, Private Placement Offerings

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, has closed on its registered direct offering and concurrent private placement with a single healthcare-focused institutional investor; the offerings were priced at-the-market under Nasdaq rules. According to the announcement, for the registered direct offering, INM issued 4,079,256 common shares at a purchase price of $0.858 per share (or prefunded warrant in lieu thereof). For the concurrent private placement, InMed issued and sold to the investor 1,748,250 common shares (or prefunded warrant in lieu thereto); those shares were offered at the same purchase price as those associated with the registered direct offering. InMed noted that it also issued unregistered preferred investment options to the investor; those investment options allowed for the purchase of up to 5,827,506 common shares. The announcement also outlined amendments to existing warrants that had been previously issued to the same investor. According to the announcement, the company could see gross proceeds from both offerings reach an estimated $5 million. InMed anticipates using the net proceeds from the offerings to continue pipeline development and advance commercial activities as well for general working capital purposes.

To view the full press release, visit https://cnw.fm/91OXR

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals is a global leader in the research, development, manufacturing and commercialization of rare cannabinoids. Together with its subsidiary BayMedica LLC, the company has unparalleled cannabinoid manufacturing capabilities to serve a spectrum of consumer markets, including pharmaceutical and health and wellness. InMed is a clinical-stage company developing a pipeline of rare cannabinoid therapeutics and is dedicated to delivering new treatment alternatives to patients who may benefit from cannabinoid-based pharmaceutical drugs. For more information, please visit www.InMedPharma.com.  

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://cnw.fm/INM

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Regulators in New York Urge Tiktok to Desist from Banning Educative Cannabis Content

Cannabis regulators in New York are asking that TikTok put an end to the ban placed on advertising anything involving the word cannabis, as they promote public education on New York’s move to legalize the herb. The state’s Office of Cannabis Management sent a letter to the social media app’s executives urging them to amend the platform’s policy on advertisement for government entities so they could talk about cannabis in a public health and safety context freely.

Chris Alexander, the office’s executive director, also revealed that the office had launched a campaign to inform residents in the state about how they could safely use marijuana, where they could legally use it and who could purchase it.

Alexander stated that the office was airing advertisements from this campaign on billboards in the state, on broadcast television and on a number of social media platforms. He noted, however, that the office was not allowed to air the advertisements on TikTok. He explained that the cannabis management office hopes that it could be permitted to run public health campaigns on cannabis, which are similar to the ads run by the state’s Department of Health on this particular platform. He added that TikTok was a valuable asset when it came to advertising because the application has more than a billion users.

Over 70% of TikTok users are aged between 18 and 34, which may assist regulators in straightening out any misinformation on who is allowed to purchase or possess cannabis when retailers launch their businesses later in the year. Currently, individuals aged 21 and above will be allowed to use, possess and purchase marijuana under the state’s legal adult-use market.

Allowing cannabis regulators to run ads on the platform would offer information to underage individuals on the effects of cannabis use at a young age while also delivering the message that it’s both illegal and unsafe to drive while impaired by marijuana.

The relationship between cannabis regulators, influencers and businesses and social media companies has been inconsistent and complicated amid the movement to legalize the herb. For instance, advocacy groups, state-legal marijuana businesses and government entities such as the California Bureau of Cannabis Control have accused Facebook of shadow banning them, which prevents their profile pages from coming up during a search.

This same issue has also been highlighted on Instagram, which is owned by Facebook, with some individuals revealing that their accounts were deleted on the application over cannabis-related content.

The continued ban of cannabis advertising by these platforms in state-legal markets denies duly licensed ancillary companies such as Advanced Container Technologies Inc. (OTC: ACTX) from accessing a large pool of their potential clients who are active on those social media platforms.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Study Says California Cannabis Retailers Fully Compliant in Checking IDs

A new study coming out of California has revealed that marijuana retailers in the state are doing a bang-up job at keeping underage people away from their merchandise. One of the major arguments against legalizing cannabis has been that it would increase youth access to the controversial drug and lead to an explosion of drug abuse and criminal activity.

To see whether or not California’s cannabis industry was compliant with state ID requirements, researchers sent 50 fresh-faced people to random cannabis dispensaries across the state. Each of the marijuana shops asked for an ID before admitting the decoys.

The study’s authors said that while the 100% compliance was somewhat surprising, it is in line with what has been seen in Colorado and Washington State. This compliance is most likely due to the penalties cannabis retailers face if they sell their products to underage people.

For starters, any Californian who provides marijuana to an underage individual faces a maximum fine of $500 and up to six months in jail for a first offense. Furthermore, the state allows police officers to test compliance to ID requirements using minors as decoys. Retailers who don’t comply can lose their retail license and face other penalties.

Published in the “Journal of Safety Research,” study findings says that since underage individuals don’t appear to be purchasing marijuana from legal outlets, it is likely they are getting it from other sources. This includes older siblings and friends, asking adults to obtain the drug on their behalf, or at parties where marijuana is being used and shared among the partygoers.

Although study authors acknowledged that their study provides evidence of policy compliance by cannabis retailers, they encouraged enforcement agencies and future studies to investigate the use of fake IDs at legal retailers by minors, and whether or not they were obtaining cannabis from social sources or illicit dispensaries.

This study is significant in two ways. First, it shows that current marijuana policies are effective at preventing youth access and second, that a legal, regulated marijuana market for adults is a much better alternative to total prohibition. It is consistent with results from several previous studies and reports.

One recent report from the Coalition for Cannabis Policy Education and Regulation (CPEAR) highlighted studies that proved that legalization did not lead to increased youth marijuana use rates.

One federally funded study also showed that 2021 saw a significant reduction in youth cannabis use while the National Survey on Drug Use and Health (NSDUH) revealed that cannabis use among the youth dropped in 2020.

Such research findings provide more vindication for the entire cannabis industry, including companies such as American Cannabis Partners, regarding the ability of legalization to curb underage marijuana access or use.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX), Growpods Spotlighted in Borgen Magazine Article

Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of self-contained, automated, indoor “micro-farms” called GrowPods, along with related equipment and supplies, were featured in an article published in Borgen magazine. The article, titled “How GrowPods Are Aiding Global Food Security,” notes that ACTX’s GrowPods “have the potential to help achieve global food security.” Noting that the consequences of global food insecurity are enormous, the article reports that Advanced Container Technologies and the innovative GrowPods may help solve the issue of global food shortages. Because the modular hydroponic farms can be located anywhere and provide an easily, accessible way to grow crops, GrowPods are a viable solution. The article also noted that GrowPods eliminate the problems of pests and disease. “Locusts and other insects ravage crops, destroying entire fields in the blink of an eye,” the article states, noting that the pods may help prevent nutrition as well. “Plants can pick up disease in any number of environments, as it is a long journey from field to consumer. . . .  The container farms perform equally well in rural and urban environments.”

For more information, view the full press release

About Advanced Container Technologies Inc.

Advanced Container Technologies is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called Grow Pods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer(R), that store and grind pharmaceuticals, herbs, teas and other solids or liquids. For more information, visit the company’s website at www.AdvancedContainerTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to ACTX are available in the company’s newsroom at https://cnw.fm/ACTX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Takes First Regulatory Step with FDA for Development of DehydraTECH-CBD in Treating Hypertension

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has successfully filed a pre-Investigational New Drug (“IND”) meeting request letter with the U.S. Food and Drug Administration (“FDA”). According to the update, the FDA has already responded to and confirmed Lexaria’s filing and has provided a target date of July 30, 2022, subject to certain conditions being met. “We are excited to take this important first regulatory step with the FDA for the development of our DehydraTECH-CBD for the treatment of hypertension,” said John Docherty, president of Lexaria. “Submission of this request letter initiates formal communication with the FDA regarding our IND clinical trial plans, in order to help define the critical path for clinical development and marketing approval of our potentially very significant new hypertension therapeutic.”

For more information, view the full press release

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 25 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Flora Growth Corp. (NASDAQ: FLGC) Bolsters its Global Expansion Strategy with Cannabis Regulatory Veteran Holly Bell’s Appointment; Hosts Regulatory Webinar

  • Flora Growth has appointed regulatory veteran Holly Bell as the new Vice President of Regulatory Affairs
  • Bell will help further the company’s domestic and global expansion strategy and lead government relations in key international markets
  • She will also oversee the regulatory strategy supporting the advancement of the company’s cultivation, distribution, and pharmaceutical programs
  • Bell also participated in the first event in her new position- the Florida Industrial Hemp Conference and Exhibition held on May 20-22, 2022

In recent months, Flora Growth (NASDAQ: FLGC) has been on an aggressive international expansion plan that has seen exports to Mexico and Spain, with an established presence in the U.K. and E.U.

In a move to strengthen the company’s global expansion strategy further, Flora Growth recently announced the appointment of regulatory veteran Holly Bell as the new Vice President of Regulatory Affairs. Bell will also be responsible for leading government relations in key international markets (https://cnw.fm/HxZ7j).

“I am excited to be working with Flora, supporting our work on the global stage, by advancing how the world views cannabis as a product and as a medicine,” she noted.

“I’m looking forward to leveraging my experience launching Florida’s hemp program to help Flora improve access to some of the best wellness brands in the world. From our leadership and brand teams to our valued scientists and cultivators, every part of the Flora organization is decided to providing safe, legal, and accessible cannabis products to consumers globally,” she added.

Bell has extensive experience in the cannabis sector, having worked as a cannabis consultant across the United States helping to build the infrastructure for industrial hemp programs. Most recently, she was the Florida Department of Agriculture and Consumer Services’ first Director of Cannabis. This agency fosters the creation of manufacturing, cultivation, and sales programs in the state. 

Through her previous positions, Bell has worked with leading regulators throughout Florida to create the first commercial hemp program in the state and develop an extensive educational series on the same program. She has also advised leading financial institutions on compliance to assist them in offering banking services to cannabis businesses.

“Holly’s unique knowledge and understanding of the United States’ regulatory framework will position us to make thoughtful, educated, and bold decisions regarding strategic distribution, cultivation, and sales plans,” noted Luis Merchan, Flora Growth’s President and Chief Executive Officer.

“We look forward to bringing Holly’s enterprise to our growing roster of industry standouts and working closely with governments worldwide to break down the barriers to the cannabis trade,” he added.

Bell will oversee the regulatory strategy supporting the advancement of Flora’s cultivation, distribution, and pharmaceutical programs, including its regulatory submissions and interactions with government authorities worldwide. She will also work towards developing and expanding a curriculum produced in partnership with EdEx that educates university students, companies, and governments about the business of cannabis.

The Florida Industrial Hemp Conference and Exhibition was Bell’s first event in her new position at Flora Growth. The event centered on advancing the industrial hemp industry in Florida and across the United States. Bell offered an overview of the state’s hemp program, which she helped leading state regulators develop (https://cnw.fm/poaqh).

The conference followed the Cannabis Regulatory Landscape webinar, where Bell, Jason Warnock, Flora Growth’s COO, and Mr. Merchan explored the nuances of working within the global cannabis regulatory framework. Discussions in the webinar included an overview of the opportunities and challenges for Flora and other cannabis companies operating in the U.S., Colombia, and other global markets, along with the importance of working closely with government entities.

The other topics covered in the webinar included what to expect from crucial bills to increase accessibility and market opportunities for Flora Growth and which markets continue to show substantial promise.

Bell holds a bachelor’s degree in Agricultural Economics from Purdue University and is a tenured consultant with experience working in the entertainment, cannabis, and banking spaces.

For more information, visit the company’s website at www.FloraGrowth.com.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Cannabis MSOs Hire Prominent Law Firm to Sue Federal Government

Some cannabis firms and stakeholders have joined forces to take the U.S. federal government to court because of policies that they consider to be violate the constitution. They hope to triumph over these prohibition policies, which they argue have impeded their operations. Boies Schiller Flexner LLP will represent the multistate operators’ coalition in court.

David Boies, chairman of the selected law firm, has been involved in a number of high-profile federal cases. The firm’s clientele list has included former U.S. vice president Al Gore and the Justice Department as well as the plaintiffs during the case that led to reversing the ban of same-sex marriages in the state of California.

In a recent interview, Ascend Wellness Holdings CEO and founder Abner Kurtin stated that the suits were an undertaking involving the entire cannabis industry and included one suit which would challenge the 280E provision that hinders the marijuana industry from receiving tax deductions which other companies can take. Another suit is focused on preventing the federal government from impeding marijuana commerce across state borders.

TerrAscend and Curaleaf as well as the American Trade Association of Cannabis and Hemp (ATACH) are some of the prospective supporters of this initiative. ATACH President Michael Bronstein stated in an interview that the group believed that the Internal Revenue Code’s 280E provision and the Controlled Substances Act weren’t being properly applied to legitimate businesses. While he didn’t reveal that ATACH was involved in the ongoing litigation effort, Bronstein did add that the organization was focused on continuing to explore and assess the possible legal options.

The organizations plan to file a pair of lawsuits in federal district court, one of which will call into question the Controlled Substances Act’s constitutionality, and the other, which will take aim at the Internal Revenue Code. The Internal Revenue Code doesn’t allow marijuana businesses to claim federal tax deductions because they are considered to be trafficking in controlled substances.

This IRS issue being resolved could allow marijuana companies that haven’t been able to access federal tax relief to amend their prior tax returns and take deductions.

If the challenge to the status of cannabis under the Controlled Substances Act is successful, this may afford marijuana businesses access to both major stock exchanges and the banking system. Currently, cannabis businesses are operating mostly on a cash-only basis, which makes them targets of crime. This comes as advocates, congressional legislators and state officials have been calling for the SAFE Banking Act to be approved.

At this point, however, it is yet to be determined which federal district courts the suits will be filed in. Plant-touching and ancillary companies such as Advanced Container Technologies Inc. (OTC: ACTX) are likely to follow this particular case since it has potentially huge ramifications for the cannabis industry.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.